Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
The Medical Journal of Australia
|
September 7, 1987
Maintenance therapies in schizophrenia
H A Whiteford, C A Peabody, M D Warner, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1994
The effect of chronic alprazolam on sleep and bioamine metabolites in depression
V P Zarcone, K L Benson, K A Greene, et al.
Neuroimage
|
December 9, 2000
Bayesian construction of geometrically based cortical thickness metrics
M I Miller, A B Massie, J T Ratnanather, et al.
Biological Psychiatry
|
April 1, 1995
Platelet serotonin markers and depressive symptomatology
Y I Sheline, M E Bardgett, J L Jackson, et al.
Psychiatry Research
|
September 29, 1995
Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder
E C Nelson, Y I Sheline, M E Bardgett, et al.
Archives of General Psychiatry
|
June 1, 1996
Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet
E F Coccaro, R J Kavoussi, Y I Sheline, et al.
Life Sciences
|
January 24, 1983
Dopaminergic supersensitivity at distant sites following induced epileptic foci
J G Csernansky, C A Holman, K A Bonnet, et al.
The Journal of Nervous and Mental Disease
|
February 1, 1987
Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics
E S Prosser, J G Csernansky, J Kaplan, et al.
Biological Psychiatry
|
August 1, 1987
The effect of age on baseline and postdexamethasone cortisol levels in major depressive disorder
H A Whiteford, C A Peabody, S Thiemann, et al.
Psychiatry Research
|
September 1, 1990
Growth hormone response to growth hormone releasing hormone in depression and schizophrenia
C A Peabody, M D Warner, E Markoff, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
The Medical Journal of Australia
|
September 7, 1987
Maintenance therapies in schizophrenia
H A Whiteford, C A Peabody, M D Warner, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1994
The effect of chronic alprazolam on sleep and bioamine metabolites in depression
V P Zarcone, K L Benson, K A Greene, et al.
Neuroimage
|
December 9, 2000
Bayesian construction of geometrically based cortical thickness metrics
M I Miller, A B Massie, J T Ratnanather, et al.
Biological Psychiatry
|
April 1, 1995
Platelet serotonin markers and depressive symptomatology
Y I Sheline, M E Bardgett, J L Jackson, et al.
Psychiatry Research
|
September 29, 1995
Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder
E C Nelson, Y I Sheline, M E Bardgett, et al.
Archives of General Psychiatry
|
June 1, 1996
Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet
E F Coccaro, R J Kavoussi, Y I Sheline, et al.
Life Sciences
|
January 24, 1983
Dopaminergic supersensitivity at distant sites following induced epileptic foci
J G Csernansky, C A Holman, K A Bonnet, et al.
The Journal of Nervous and Mental Disease
|
February 1, 1987
Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics
E S Prosser, J G Csernansky, J Kaplan, et al.
Biological Psychiatry
|
August 1, 1987
The effect of age on baseline and postdexamethasone cortisol levels in major depressive disorder
H A Whiteford, C A Peabody, S Thiemann, et al.
Psychiatry Research
|
September 1, 1990
Growth hormone response to growth hormone releasing hormone in depression and schizophrenia
C A Peabody, M D Warner, E Markoff, et al.
Page
of 14